SEC Form 4 · accession 0001144204-17-048335
PHIBRO ANIMAL HEALTH CORP · PAHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard G Johnson
Officer — Chief Financial Officer
Period of report
Sep 13, 2017
Accepted (ET)
Sep 15, 2017 · 8:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001069899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Sep 13, 2017 | M | 15,900 | $11.83 | A | 15,900 | D | |
| Class A Common StockF2 | Sep 13, 2017 | S | 15,900 | $36.46 | D | 0 | D | |
| Class A Common Stock | Sep 14, 2017 | M | 6,479 | $11.83 | A | 6,479 | D | |
| Class A Common StockF3 | Sep 14, 2017 | S | 6,479 | $36.23 | D | 0 | D | |
| Class A Common Stock | Sep 14, 2017 | M | 33,150 | $11.83 | A | 33,150 | D | |
| Class A Common StockF4 | Sep 14, 2017 | S | 33,150 | $36.23 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase Common Stock | $11.83 | Sep 13, 2017 | M | 15,900 | D | Mar 1, 2013 | Feb 28, 2019 | Class A Common Stock | 15,900 | 6,479 | D |
| Option to purchase Common Stock | $11.83 | Sep 14, 2017 | M | 6,479 | D | Mar 1, 2013 | Feb 28, 2019 | Class A Common Stock | 6,479 | 0 | D |
| Option to purchase Common Stock | $11.83 | Sep 14, 2017 | M | 33,150 | D | Mar 1, 2014 | Feb 28, 2019 | Class A Common Stock | 33,150 | 0 | D |
Explanation of responses
- F1The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.30 to $36.65, inclusive.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.05 to $36.55, inclusive.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.05 to $36.55, inclusive.